Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
INBX
INBX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
INBX News
Inhibrx Biosciences Options Risk Analysis
Jan 30 2026
NASDAQ.COM
Palvella Therapeutics Stock Soars to $114.69 Following Pipeline Developments
Dec 31 2025
NASDAQ.COM
Inhibrx Stock Surges 150% Post Ozekibart Trial Results but Faces Structural Risks
Dec 24 2025
Benzinga
Inhibrx Progresses with INBRX-106 and Ozekibart Programs, Anticipates Major Milestones in the Coming Year
Dec 17 2025
NASDAQ.COM
Inhibrx Advances INBRX-106 Clinical Trials, Enrolls 46 Patients
Dec 16 2025
PRnewswire
Top Quant-Rated Small and Mid-Cap Healthcare Stocks as LLY Reaches $1 Trillion Market Capitalization
Nov 21 2025
SeekingAlpha
INBX Progresses Ozekibart Initiative, Aims for BLA Submission for Chondrosarcoma by Q2 2026
Nov 17 2025
NASDAQ.COM
Inhibrx Reports Third Quarter 2025 Financial Results
Nov 14 2025
PRnewswire
Biotech Stocks Reach 52-Week Peaks: MTSR, INSM, ABVX, and MAZE Drive Surge on October 30
Oct 31 2025
NASDAQ.COM
US Stocks Reach Record Highs as Inflation Weakens: Investor Anxiety Diminishes, Greed Index Stays in 'Fear' Territory
Oct 27 2025
Benzinga
Markets Surge to New Highs Following Low Inflation; Ford Rises 10%: Key Market Movers on Friday
Oct 24 2025
Benzinga
Dow Surges More Than 500 Points as US Consumer Sentiment Falls in October
Oct 24 2025
Benzinga
Major Stocks on the Rise Friday: Ford, Inhibrx Biosciences, Comfort Systems, Western Union, and More
Oct 24 2025
Benzinga
What’s Driving the Surge in Inhibrx Biosciences Stock (INBX) Today?
Oct 24 2025
TipRanks
Intel Shares Rise Approximately 8%; Check Out 20 Stocks Making Moves in Premarket Trading
Oct 24 2025
Benzinga
What’s Behind the 76% Surge in Inhibrx Biosciences Shares After Hours?
Oct 24 2025
Benzinga
Show More News
